DoP to come up with FAQs to provide clarification on PLI scheme
The Department of Pharmaceuticals (DoP) is in the process of compiling and publishing a list of Frequently Asked Questions (FAQs) based on queries raised or clarifications sought by the industry in connection with the production linked incentive (PLI) scheme for pharmaceuticals. The department has 17 Foreign Direct Investment (FDI) proposals
DoP revises guidelines for PLI scheme for promotion
The Department of Pharmaceuticals (DoP) has revised the guidelines for the production linked incentive (PLI) scheme for promoting domestic manufacturing of medical devices, dividing the eligible products into two categories and allocating incentives separately for them.
DoP to launch revised PLI scheme guidelines - Express Pharma
The Department of Pharmaceuticals plans to launch revised PLI scheme guidelines. It is likely that in the revised PLI scheme the government has considered the industry’s request to remove the minimum investment criteria and may include export and sale-based production criteria.
DoP yet to select applicants for 15
The Department of Pharmaceuticals (DoP) is yet to select applicants for 15 molecules out of the total 41 molecules under the PLI scheme since its launch in July 21, 2025 to boost domestic...
Government issues Operational guidelines for PLI scheme
PLI scheme for bulk drugs or any other PLI scheme to high of the country and change India’s Comments a. The scheme may facilitate product diversification value goods in the pharmaceutical sector image as a manufacturer and exporter of drugs and medical devices. b. It would be advisable for the desired applicants to
